- Home
- VHC vs ELUT Comparison
VHC vs ELUT Comparison
Compare VHC & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VHC | ELUT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 42.5M |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VHC | ELUT |
|---|---|---|
| Price | $12.85 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 18.1K | ★ 46.5K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.99 | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | $162,000.00 | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3140.00 | N/A |
| 52 Week Low | $9.82 | $0.50 |
| 52 Week High | $29.00 | $2.50 |
Technical Indicators
Market Signals| Indicator | VHC | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 44.02 |
| Support Level | $11.43 | $0.89 |
| Resistance Level | $13.58 | $1.00 |
| Average True Range (ATR) | 0.94 | 0.06 |
| MACD | 0.22 | -0.00 |
| Stochastic Oscillator | 60.30 | 33.33 |
Price Performance
Historical ComparisonAbout VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. Its software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.